APA (7th ed.) Citation

Ichikawa, S., Muratani, S., Sano, K., Erami, K., Mori, A., Matsumoto, R., & Ito, S. Quantitative adverse outcome pathway modeling for cigarette-smoke-induced airway mucus hypersecretion. Part 1: Adverse-outcome-pathway-based in vitro assessment with repeated exposure to whole cigarette smoke. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Ichikawa, Sakuya, Shugo Muratani, Keigo Sano, Kazuo Erami, Akina Mori, Risa Matsumoto, and Shigeaki Ito. Quantitative Adverse Outcome Pathway Modeling for Cigarette-smoke-induced Airway Mucus Hypersecretion. Part 1: Adverse-outcome-pathway-based in Vitro Assessment with Repeated Exposure to Whole Cigarette Smoke. Frontiers Media S.A.

MLA (9th ed.) Citation

Ichikawa, Sakuya, et al. Quantitative Adverse Outcome Pathway Modeling for Cigarette-smoke-induced Airway Mucus Hypersecretion. Part 1: Adverse-outcome-pathway-based in Vitro Assessment with Repeated Exposure to Whole Cigarette Smoke. Frontiers Media S.A.